Author:
Grimaldi Daniele,Genuardi Elisa,Ferrante Martina,Ferrero Simone,Ladetto Marco
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference54 articles.
1. Solal-Celigny P. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–65.
2. Massimo F, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27:4555–62.
3. Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study. J Clin Oncol. 2015;33:2516–22.
4. Nagham NO, Abolela MS, Abdelgawad MI, Ibrahim A, Mourad AF, Rezk K. Diagnostic Utility of 18F-FDG PECT/CT in Assessment of Post-therapy Remission or Relapse of Lymphoma. Cancer Res Treat. 2016;4(5):88–95.
5. Trotman J, Luminari S, Boussetta S, Versari A, Dupuis J, Tychyj C, et al. Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies. Lancet Haematol. 2014;1:e17–27.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献